Publicada a RDC Anvisa. 371 que altera RDC n° 370, de 13 de abril de 2020, que dispõe sobre a autorização prévia para fins de exportação de matéria-prima, produto semi-elaborado, produto a granel ou produto farmacêutico acabado destinados ao combate da COVID-19 / Anvisa RDC published. 371 amending RDC n ° 370, of April 13, 2020, which provides for prior authorization for the purpose of exporting raw materials, semi-finished products, bulk products or finished pharmaceutical products intended to combat COVID-19
Brasília; CONASS; abr. 2020. (CONASS informa, 191).
Monography
in Portuguese
| CONASS, LILACS
| ID: biblio-1100566
Subject(s)
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Pneumonia, Viral
/
Pharmaceutical Preparations
/
Quarantine
/
Coronavirus Infections
/
Pandemics
/
Betacoronavirus
Language:
Portuguese
Journal:
CONASS informa
Year:
2020
Type:
Monography
Similar
MEDLINE
...
LILACS
LIS